Chao Tung Wen
Directeur/Membre du Conseil chez TATUNG SYSTEM TECHNOLOGIES INC.
Postes actifs de Chao Tung Wen
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| TATUNG SYSTEM TECHNOLOGIES INC. | Directeur/Membre du Conseil | 24/06/2013 | - |
| Independent Dir/Board Member | 24/06/2013 | - | |
| National Chengchi University | Corporate Officer/Principal | - | - |
Historique de carrière de Chao Tung Wen
Anciens postes connus de Chao Tung Wen
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| E INK HOLDINGS INC. | Directeur/Membre du Conseil | 18/06/2014 | - |
| Independent Dir/Board Member | 18/06/2014 | - | |
| Eastern Ad | Président | - | - |
| PHARMADAX INC. | Directeur/Membre du Conseil | 27/09/2013 | - |
| Independent Dir/Board Member | 27/09/2013 | - |
Formation de Chao Tung Wen
| Tunghai University | Undergraduate Degree |
| Rochester Christian University | Masters Business Admin |
| Rensselaer Polytechnic Institute | Doctorate Degree |
Statistiques
Internationale
| Taïwan | 7 |
| Etats-Unis | 3 |
Opérationnelle
| Director/Board Member | 3 |
| Independent Dir/Board Member | 3 |
| Undergraduate Degree | 1 |
Sectorielle
| Consumer Services | 5 |
| Commercial Services | 2 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| TATUNG SYSTEM TECHNOLOGIES INC. | Commercial Services |
| E INK HOLDINGS INC. | Electronic Technology |
| Entreprise privées | 2 |
|---|---|
PharmaDax Inc.
 PharmaDax Inc. Pharmaceuticals: MajorHealth Technology PharmaDax Inc. engages in the development and marketing of generic dossiers. Its products include Glyburide, Quetiapine Fumarate ER, and Metoprolol Succinate ER tablets. The company was founded by Yi Pin Huang on March 21, 2008 and is headquartered in New Taipei, Taiwan. | Health Technology |
| Eastern Ad |
- Bourse
- Insiders
- Chao Tung Wen
- Expérience
